Standard BioTools Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2021 | $-12.9M | $-19.8M | $6.9M | $3.7M |
| Jun 2021 | $-14.7M | $-18.8M | $4.2M | $3.7M |
| Sep 2021 | $-9.5M | $-11.2M | $1.7M | $4.3M |
| Dec 2021 | $-7.0M | $-7.5M | $463.0K | $4.4M |
| Mar 2022 | $-15.6M | $-16.5M | $868.0K | $4.0M |
| Jun 2022 | $-30.0M | $-30.9M | $938.0K | $4.7M |
| Sep 2022 | $-24.6M | $-25.9M | $1.3M | $4.5M |
| Dec 2022 | $-19.2M | $-19.9M | $755.0K | $1.7M |
| Mar 2023 | $-8.5M | $-9.5M | $1.0M | $3.1M |
| Jun 2023 | $-9.3M | $-10.2M | $838.0K | $3.1M |
| Sep 2023 | $-11.4M | $-12.3M | $905.0K | $3.4M |
| Dec 2023 | $-14.1M | $-14.1M | $78.0K | $3.5M |
| Mar 2024 | $-62.5M | $-63.3M | $781.0K | $11.6M |
| Jun 2024 | $-39.1M | $-41.0M | $1.9M | $6.7M |
| Sep 2024 | $-27.9M | $-30.1M | $2.3M | $5.9M |
| Dec 2024 | $-14.1M | $-17.4M | $3.4M | $7.5M |
| Mar 2025 | $-30.3M | $-35.3M | $5.1M | $9.0M |
| Jun 2025 | $-20.7M | $-22.6M | $1.9M | $6.4M |
| Sep 2025 | $-22.2M | $-23.1M | $886.0K | $8.5M |
| Dec 2025 | $-1.2M | $-1.7M | $476.0K | $5.7M |